$MED
MEDIFAST INC

2021 Q4 Form 10-Q Financial Statement

#000155837021014628 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $377.8M $413.4M $271.5M
YoY Change 42.63% 52.28% 42.83%
Cost Of Revenue $99.55M $106.3M $67.43M
YoY Change 51.52% 57.69% 43.09%
Gross Profit $278.3M $307.1M $204.0M
YoY Change 39.67% 50.49% 42.75%
Gross Profit Margin 73.65% 74.28% 75.16%
Selling, General & Admin $230.3M $251.9M $159.5M
YoY Change 43.61% 57.95% 30.0%
% of Gross Profit 82.77% 82.03% 78.16%
Research & Development $1.100M $1.200M $800.0K
YoY Change 22.22% 50.0% 33.33%
% of Gross Profit 0.4% 0.39% 0.39%
Depreciation & Amortization -$463.0K $2.635M $1.800M
YoY Change -123.15% 46.39% 50.0%
% of Gross Profit -0.17% 0.86% 0.88%
Operating Expenses $231.4M $251.9M $159.5M
YoY Change 43.58% 57.95% 30.0%
Operating Profit $46.84M $55.17M $44.56M
YoY Change 23.13% 23.82% 119.91%
Interest Expense -$93.00K -$94.00K $44.00K
YoY Change -313.64% -86.42%
% of Operating Profit -0.2% -0.17% 0.1%
Other Income/Expense, Net $7.000K $21.00K $74.00K
YoY Change -103.5% -71.62% -76.95%
Pretax Income $46.75M $55.19M $44.63M
YoY Change 23.52% 23.66% 116.84%
Income Tax $12.73M $13.21M $10.18M
% Of Pretax Income 27.23% 23.93% 22.81%
Net Earnings $34.02M $41.98M $34.45M
YoY Change 21.54% 21.85% 116.66%
Net Earnings / Revenue 9.0% 10.16% 12.69%
Basic Earnings Per Share $3.59 $2.93
Diluted Earnings Per Share $2.900M $3.56 $2.91
COMMON SHARES
Basic Shares Outstanding 11.62M 11.69M 11.77M
Diluted Shares Outstanding 11.79M 11.86M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $213.7M $314.4M $326.4M
YoY Change -36.8% -3.67% 83.26%
Cash & Equivalents $104.2M $154.5M $156.5M
Short-Term Investments $109.5M $159.9M $169.9M
Other Short-Term Assets $16.33M $11.54M $5.200M
YoY Change 176.85% 121.94% 8.33%
Inventory $180.0M $129.6M $41.74M
Prepaid Expenses
Receivables $647.0K
Other Receivables $0.00
Total Short-Term Assets $306.9M $301.1M $217.5M
YoY Change 30.96% 38.44% 37.37%
LONG-TERM ASSETS
Property, Plant & Equipment $56.13M $46.45M $26.83M
YoY Change 103.13% 73.14% 2.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.468M $6.439M $3.002M
YoY Change 120.22% 114.49% 562.69%
Total Long-Term Assets $91.46M $70.32M $43.33M
YoY Change 118.96% 62.28% 7.57%
TOTAL ASSETS
Total Short-Term Assets $306.9M $301.1M $217.5M
Total Long-Term Assets $91.46M $70.32M $43.33M
Total Assets $398.3M $371.4M $260.8M
YoY Change 44.28% 42.4% 31.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $163.3M $155.5M $108.7M
YoY Change 51.63% 43.06% 44.93%
Accrued Expenses $6.523M $5.402M $3.300M
YoY Change 76.3% 63.7% 32.0%
Deferred Revenue $8.050M
YoY Change 5.84%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $169.8M $160.9M $112.0M
YoY Change 52.52% 43.69% 44.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $26.02M $14.22M $8.800M
YoY Change 246.93% 61.6% -11.11%
Total Long-Term Liabilities $26.02M $14.22M $8.800M
YoY Change 246.93% 61.6% -11.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $169.8M $160.9M $112.0M
Total Long-Term Liabilities $26.02M $14.22M $8.800M
Total Liabilities $195.9M $175.1M $120.8M
YoY Change 64.81% 45.0% 38.21%
SHAREHOLDERS EQUITY
Retained Earnings $190.3M $183.2M $139.8M
YoY Change 23.31% 31.04% -14.2%
Common Stock $12.00K $12.00K $12.00K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $202.5M $196.2M $140.0M
YoY Change
Total Liabilities & Shareholders Equity $398.3M $371.4M $260.8M
YoY Change 44.28% 42.4% 31.32%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $34.02M $41.98M $34.45M
YoY Change 21.54% 21.85% 116.66%
Depreciation, Depletion And Amortization -$463.0K $2.635M $1.800M
YoY Change -123.15% 46.39% 50.0%
Cash From Operating Activities -$7.459M $15.80M $41.10M
YoY Change -137.67% -61.56% 129.61%
INVESTING ACTIVITIES
Capital Expenditures -$11.62M -$10.39M -$3.300M
YoY Change 481.2% 214.82% 50.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $1.000M
YoY Change -100.0% -100.0% -23.08%
Cash From Investing Activities -$11.62M -$10.39M -$2.300M
YoY Change -2037.33% 351.7% 130.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -31.23M -42.94M -13.20M
YoY Change 138.41% 225.34% -58.88%
NET CHANGE
Cash From Operating Activities -7.459M 15.80M 41.10M
Cash From Investing Activities -11.62M -10.39M -2.300M
Cash From Financing Activities -31.23M -42.94M -13.20M
Net Change In Cash -50.31M -37.53M 25.60M
YoY Change -789.25% -246.62% -268.42%
FREE CASH FLOW
Cash From Operating Activities -$7.459M $15.80M $41.10M
Capital Expenditures -$11.62M -$10.39M -$3.300M
Free Cash Flow $4.165M $26.19M $44.40M
YoY Change -80.89% -41.02% 120.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Income Loss
OperatingIncomeLoss
169404000
us-gaap Operating Income Loss
OperatingIncomeLoss
96191000
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
93000
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
91000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
101000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
68000
dei Entity Central Index Key
EntityCentralIndexKey
0000910329
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31573
dei Entity Registrant Name
EntityRegistrantName
Medifast, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3714405
dei Entity Address Address Line1
EntityAddressAddressLine1
100 International Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Baltimore
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21202
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
581-8042
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MED
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11616233
CY2021Q3 us-gaap Revenues
Revenues
413395000
CY2020Q3 us-gaap Revenues
Revenues
271470000
us-gaap Revenues
Revenues
1148253000
us-gaap Revenues
Revenues
669930000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
106338000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
67434000
us-gaap Cost Of Revenue
CostOfRevenue
298942000
us-gaap Cost Of Revenue
CostOfRevenue
171354000
CY2021Q3 us-gaap Gross Profit
GrossProfit
307057000
CY2020Q3 us-gaap Gross Profit
GrossProfit
204036000
us-gaap Gross Profit
GrossProfit
849311000
us-gaap Gross Profit
GrossProfit
498576000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
96415000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13210000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10180000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.36
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39370000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.56
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.32
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11692000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11766000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21550000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11739000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11772000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11785000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11857000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
251886000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
159477000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
74000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
679907000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
402385000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
224000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55192000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
55171000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
44559000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44633000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
169378000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-94000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
44000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-138000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
212000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
115000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
112000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
41982000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34453000
us-gaap Net Income Loss
NetIncomeLoss
130008000
us-gaap Net Income Loss
NetIncomeLoss
74865000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.59
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.93
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11840000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11840000
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.42
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.13
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
4.26
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
3.39
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
41982000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34453000
us-gaap Net Income Loss
NetIncomeLoss
130008000
us-gaap Net Income Loss
NetIncomeLoss
74865000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
63000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
130000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-16000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-49000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
75000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
47000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
81000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
72000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
42029000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34451000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
130089000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
74937000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154516000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
163723000
CY2021Q3 us-gaap Inventory Net
InventoryNet
129614000
CY2020Q4 us-gaap Inventory Net
InventoryNet
53392000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
5379000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
10752000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11541000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6447000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
301050000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
234314000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46451000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27633000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16736000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10508000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6439000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2937000
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
692000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
692000
CY2021Q3 us-gaap Assets
Assets
371368000
CY2020Q4 us-gaap Assets
Assets
276084000
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
155506000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
107677000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5402000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3673000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
160908000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
111350000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14221000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7488000
CY2021Q3 us-gaap Liabilities
Liabilities
175129000
CY2020Q4 us-gaap Liabilities
Liabilities
118838000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
46000
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
5000000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
196239000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
157246000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
371368000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
276084000
us-gaap Net Income Loss
NetIncomeLoss
130008000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1728000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3393000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2566000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
42747000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
30078000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
102004000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11618000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11822000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11616000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11772000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
12000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
12000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12950000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7842000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
122000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
183155000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
154351000
us-gaap Net Income Loss
NetIncomeLoss
74865000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7275000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5259000
us-gaap Share Based Compensation
ShareBasedCompensation
6613000
us-gaap Share Based Compensation
ShareBasedCompensation
4243000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-28000
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
70000
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
263000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-735000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
76222000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7035000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-5169000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5094000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
125367000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5145000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22585000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3852000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17440000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1852000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
811000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1424000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
1867000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
532000
us-gaap Payments Of Dividends
PaymentsOfDividends
46845000
us-gaap Payments Of Dividends
PaymentsOfDividends
39892000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-93901000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44000000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
130000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9207000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
79512000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163723000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76974000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154516000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156486000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
41302000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14135000
us-gaap Dividends Cash
DividendsCash
17351000
us-gaap Dividends Cash
DividendsCash
13715000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
157246000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
41063000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2198000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
481000
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1807000
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7500000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
62000
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16852000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
174891000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
46963000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1839000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
221000
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
26000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28000
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12230000
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16941000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
194689000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
41982000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2269000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
109000
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
34000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
47000
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26270000
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16553000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
196239000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
104832000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
18477000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
981000
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
487000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13099000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
110749000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
21935000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1136000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1250000
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
29000
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5000000
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13354000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
116736000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34453000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2126000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
174000
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
36000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13437000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
140014000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reclassification -</b> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates</b> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</p>
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11857000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11840000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11840000
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
13840000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
13428000
CY2021Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
3395000
CY2020Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
4071000
CY2021Q3 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
15407000
CY2020Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
8078000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
100688000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
29858000
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3716000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2043000
CY2021Q3 us-gaap Inventory Net
InventoryNet
129614000
CY2020Q4 us-gaap Inventory Net
InventoryNet
53392000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
41982000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34453000
us-gaap Net Income Loss
NetIncomeLoss
130008000
us-gaap Net Income Loss
NetIncomeLoss
74865000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11692000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11766000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11739000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11785000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11772000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.59
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.36
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.56
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.32
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
800000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1400000
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
7226
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
5432
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2300000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2100000
us-gaap Share Based Compensation
ShareBasedCompensation
6600000
us-gaap Share Based Compensation
ShareBasedCompensation
4200000
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1400000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
900000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3800000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2600000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
108000
us-gaap Operating Lease Payments
OperatingLeasePayments
3175000
us-gaap Operating Lease Payments
OperatingLeasePayments
2778000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9745000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
887000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.023
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1482000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5540000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4080000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3515000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3591000
CY2021Q3 med Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
2324000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20532000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
909000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
19623000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-22000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
14000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
63000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
122000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
159819000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
37000
CY2021Q3 us-gaap Interest Receivable
InterestReceivable
39000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
159895000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154516000
CY2021Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5379000
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
174241000
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
87000
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
147000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
174475000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
163723000
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
10752000
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2020Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2021Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0

Files In Submission

Name View Source Status
0001558370-21-014628-index-headers.html Edgar Link pending
0001558370-21-014628-index.html Edgar Link pending
0001558370-21-014628.txt Edgar Link pending
0001558370-21-014628-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
med-20210930.xsd Edgar Link pending
med-20210930x10q.htm Edgar Link pending
med-20210930x10q_htm.xml Edgar Link completed
med-20210930xex31d1.htm Edgar Link pending
med-20210930xex31d2.htm Edgar Link pending
med-20210930xex32d1.htm Edgar Link pending
med-20210930_cal.xml Edgar Link unprocessable
med-20210930_def.xml Edgar Link unprocessable
med-20210930_lab.xml Edgar Link unprocessable
med-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending